This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Japan, Lithuania, Netherlands, Romania, UK.
The drug RECARBRIO contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
Q20IM7HE75 - IMIPENEM ANHYDROUS
|
|
Imipenem is a semi-synthetic derivative of thienamycin, the parent compound produced by the filamentous bacterium Streptomyces cattleya. Imipenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). |
|
2
|
UNII
141A6AMN38 - CILASTATIN
|
3
|
Relebactam
UNII
1OQF7TT3PF - RELEBACTAM ANHYDROUS
|
|
Relebactam is a non-beta lactam inhibitor of Ambler class A and class C beta-lactamases, including class A Klebsiella pneumoniae carbapenemase (KPC) and extended-spectrum beta-lactamases (ESBLs), and class C (AmpC-type) beta-lactamases including Pseudomonas-Derived Cephalosporinase (PDC). Relebactam does not inhibit class B enzymes (metallo-beta-lactamases) or class D carbapenemases. Relebactam has no antibacterial activity. |
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| RECARBRIO Powder for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| RECARBRIO Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DH56 | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1811359 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 070677 |
| FR | Base de données publique des médicaments | 65172663 |
| GB | Medicines & Healthcare Products Regulatory Agency | 386996 |
| IT | Agenzia del Farmaco | 048537017 |
| JP | 医薬品医療機器総合機構 | 6129500D1027 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1089413 |
| NL | Z-Index G-Standaard, PRK | 203068 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W66566001 |
| US | FDA, National Drug Code | 0006-3856 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.